142 related articles for article (PubMed ID: 18547271)
1. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
Korolainen MA; Pirttilä T
Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
[TBL] [Abstract][Full Text] [Related]
2. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
Ahmed N; Ahmed U; Thornalley PJ; Hager K; Fleischer G; Münch G
J Neurochem; 2005 Jan; 92(2):255-63. PubMed ID: 15663474
[TBL] [Abstract][Full Text] [Related]
3. Oxidized proteins in Alzheimer's plasma.
Conrad CC; Marshall PL; Talent JM; Malakowsky CA; Choi J; Gracy RW
Biochem Biophys Res Commun; 2000 Aug; 275(2):678-81. PubMed ID: 10964722
[TBL] [Abstract][Full Text] [Related]
4. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.
Abe T; Tohgi H; Isobe C; Murata T; Sato C
J Neurosci Res; 2002 Nov; 70(3):447-50. PubMed ID: 12391605
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
Ryberg H; Söderling AS; Davidsson P; Blennow K; Caidahl K; Persson LI
Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.
Peskind ER; Leverenz J; Farlow MR; Ito RK; Provow SA; Siegel RS; Cleveland M; Morgan CH; Pandian MR; Corbin S; Nochlin D; Schellenberg GD; Raskind MA; Wagner SL
Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):201-6. PubMed ID: 9437437
[TBL] [Abstract][Full Text] [Related]
7. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.
Montine TJ; Quinn JF; Milatovic D; Silbert LC; Dang T; Sanchez S; Terry E; Roberts LJ; Kaye JA; Morrow JD
Ann Neurol; 2002 Aug; 52(2):175-9. PubMed ID: 12210787
[TBL] [Abstract][Full Text] [Related]
8. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
[TBL] [Abstract][Full Text] [Related]
9. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of protein oxidation in Alzheimer's disease brain.
Korolainen MA; Goldsteins G; Alafuzoff I; Koistinaho J; Pirttilä T
Electrophoresis; 2002 Sep; 23(19):3428-33. PubMed ID: 12373773
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of soluble amyloid beta-protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs.
Wagner SL; Peskind ER; Nochlin D; Provow S; Farrow JS; Pandian MR; Cleveland M; Ito RK; Farlow MR
Ann Neurol; 1994 Aug; 36(2):215-20. PubMed ID: 8053657
[TBL] [Abstract][Full Text] [Related]
12. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
Aoyama K; Matsubara K; Fujikawa Y; Nagahiro Y; Shimizu K; Umegae N; Hayase N; Shiono H; Kobayashi S
Ann Neurol; 2000 Apr; 47(4):524-7. PubMed ID: 10762167
[TBL] [Abstract][Full Text] [Related]
13. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
Isobe C; Murata T; Sato C; Terayama Y
Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
[TBL] [Abstract][Full Text] [Related]
14. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms.
Borroni B; Colciaghi F; Corsini P; Akkawi N; Rozzini L; Del Zotto E; Talarico G; Cattabeni F; Lenzi GL; Di Luca M; Padovani A
Neurol Sci; 2002 Dec; 23(5):207-10. PubMed ID: 12522675
[TBL] [Abstract][Full Text] [Related]
15. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study.
Straface E; Matarrese P; Gambardella L; Vona R; Sgadari A; Silveri MC; Malorni W
FEBS Lett; 2005 May; 579(13):2759-66. PubMed ID: 15907478
[TBL] [Abstract][Full Text] [Related]
16. Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression.
Hoogendijk WJ; Meynen G; Endert E; Hofman MA; Swaab DF
Neurobiol Aging; 2006 May; 27(5):780.e1-780.e2. PubMed ID: 16198445
[TBL] [Abstract][Full Text] [Related]
17. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease.
Kuhla B; Lüth HJ; Haferburg D; Boeck K; Arendt T; Münch G
Ann N Y Acad Sci; 2005 Jun; 1043():211-6. PubMed ID: 16037241
[TBL] [Abstract][Full Text] [Related]
18. Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease.
Choe LH; Dutt MJ; Relkin N; Lee KH
Electrophoresis; 2002 Jul; 23(14):2247-51. PubMed ID: 12210229
[TBL] [Abstract][Full Text] [Related]
19. Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease.
Kuda T; Shoji M; Arai H; Kawashima S; Saido TC
Biochem Biophys Res Commun; 1997 Feb; 231(3):526-30. PubMed ID: 9070837
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease.
Marcum JL; Mathenia JK; Chan R; Guttmann RP
Biochem Biophys Res Commun; 2005 Aug; 334(2):342-8. PubMed ID: 16018967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
